<?xml version="1.0" encoding="UTF-8"?>
<ref id="B129-microorganisms-08-00085">
 <label>129.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Clifford</surname>
    <given-names>D.B.</given-names>
   </name>
   <name>
    <surname>Nath</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cinque</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Brew</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Zivadinov</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Gorelik</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Duda</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>A study of mefloquine treatment for progressive multifocal leukoencephalopathy: Results and exploration of predictors of PML outcomes</article-title>
  <source>J. Neurovirol.</source>
  <year>2013</year>
  <volume>19</volume>
  <fpage>351</fpage>
  <lpage>358</lpage>
  <pub-id pub-id-type="doi">10.1007/s13365-013-0173-y</pub-id>
  <pub-id pub-id-type="pmid">23733308</pub-id>
 </element-citation>
</ref>
